[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Obstetrics and gynaecology](https://durgical.com/en/obstetrics-gynaecology/) › [Gynaecological oncology](https://durgical.com/en/obstetrics-gynaecology/areas/gyn-oncology/) › BRCA and Lynch syndrome: who to test and risk-reducing options

# BRCA and Lynch syndrome: who to test and risk-reducing options

- Approach to a problem

Some ovarian, breast and endometrial cancers run in families. Finding the gene lets a woman act before cancer starts, and warns her relatives.

Updated Nov 15, 2026

**See it in 3D:** [Uterine tubes](https://durgical.com/en/anatomy/uterine-tube/) · [Infundibulum and fimbriae](https://durgical.com/en/anatomy/infundibulum-of-uterine-tube/) · [Ovaries](https://durgical.com/en/anatomy/ovary/) · [Body of uterus](https://durgical.com/en/anatomy/body-of-uterus/) · [Mammary gland lobes](https://durgical.com/en/anatomy/mammary-gland/)

## Key points

- Test every woman with [epithelial ovarian cancer](https://durgical.com/en/conditions/ovarian-cancer/) for BRCA.
- Test every endometrial and [colorectal cancer](https://durgical.com/en/conditions/colorectal-cancer/) for [mismatch repair](https://durgical.com/en/biochemistry/topics/dna-repair/) (Lynch).
- [BRCA1](https://durgical.com/en/conditions/hereditary-breast-and-ovarian-cancer-syndrome/): tubes and [ovaries](https://durgical.com/en/anatomy/ovary/) out around 35 to 40; BRCA2 around 40 to 45.
- Ovarian screening does not save lives; risk-reducing surgery does.
- Lynch: [hysterectomy](https://durgical.com/en/obstetrics-gynaecology/hysterectomy-indications-routes-the-ovaries-and-tubes-and-complications/) with tubes and ovaries after childbearing, plus colonoscopy.

On this page

- The basics Key points
- What it is
- How to think about it
- Step-by-step approach
- BRCA1, BRCA2 and Lynch side by side
- Common traps
- Elsewhere in DurgiPedia

- Clinical Red flags
- Keys to the differential

- Treatment Next step / Initial management

- Study Test yourself

- Connections Connections

## What it is

BRCA1 and BRCA2 are tumour suppressor genes that repair double-strand DNA breaks by homologous recombination. An inherited faulty copy, passed on in an autosomal dominant way by mothers or fathers, raises the risk of breast and high-grade serous ovarian, tubal and peritoneal cancer, and also of pancreatic and [prostate cancer](https://durgical.com/en/conditions/prostate-cancer/) and, with BRCA2, [melanoma](https://durgical.com/en/conditions/melanoma/). [Lynch syndrome](https://durgical.com/en/conditions/lynch-syndrome/) is an inherited fault in a DNA mismatch-repair gene (MLH1, MSH2, MSH6, PMS2, or EPCAM); it raises the risk of colorectal and [endometrial cancer](https://durgical.com/en/conditions/endometrial-cancer/) above all, and of ovarian, [stomach](https://durgical.com/en/anatomy/stomach/), small bowel, urinary tract and other cancers. Testing combines a family history, tumour tests and germline testing with [genetic counselling](https://durgical.com/en/biochemistry/topics/genetic-counselling-and-risk-assessment/); carriers are offered intensive screening, risk-reducing surgery and medicines, and their relatives are offered testing.

## How to think about it

Picture two broken repair crews. BRCA is the crew that mends snapped DNA (double-strand breaks); without it, cells patch breaks badly and the tubal fimbria and breast are hit hardest. Lynch is the proof-reading crew; without it, copying errors pile up in repeated DNA (microsatellite instability), and the colon and [endometrium](https://durgical.com/en/anatomy/endometrium/) are hit hardest. You inherit one broken copy in every cell; cancer starts in a cell that loses the second copy. The same broken crew is also the tumour's weak point: [PARP inhibitors](https://durgical.com/en/pharmacology/classes/parp-inhibitors/) finish off BRCA-deficient cells, and the many mutations of Lynch tumours make them visible to immunotherapy.

## Red flags

- Any woman with epithelial ovarian, tubal or peritoneal cancer, whatever her family history: offer germline testing.
- [Breast cancer](https://durgical.com/en/conditions/breast-cancer/) at a young age, triple-negative or in both breasts, male breast cancer in the family, or relatives with ovarian, pancreatic or metastatic prostate cancer.
- An endometrial or colorectal tumour that is mismatch-repair deficient, especially at a young age.
- Several relatives on the same side with colorectal, endometrial, ovarian, stomach or urinary tract cancers, across generations.
- A known pathogenic variant in a relative: offer that specific test (cascade testing).

## Step-by-step approach

- Take a three-generation family history on both sides, with cancer types and ages at diagnosis.
- Test the tumour when there is one: mismatch-repair proteins in every endometrial and colorectal cancer; BRCA testing in ovarian cancer.
- Offer genetic counselling before testing: what a result means for her, her children and her siblings, and what can be done.
- Test an affected relative first when possible, so the family's variant is found; then offer relatives that single test.
- Positive result → a plan by gene: breast imaging, timing of risk-reducing surgery, colonoscopy for Lynch, and contraception choices.
- Negative result when the family variant is known → population risk; negative with no known variant → still manage by family history.
- [Variant of uncertain significance](https://durgical.com/en/biochemistry/topics/interpreting-genetic-variants-classes-evidence-and-databases/) → treat as uninformative and manage by family history; it may be reclassified later.

## BRCA1, BRCA2 and Lynch side by side

| Feature | BRCA1 | BRCA2 | Lynch syndrome |
| --- | --- | --- | --- |
| [Broken repair system](https://durgical.com/en/conditions/hereditary-breast-and-ovarian-cancer-syndrome/) | Homologous recombination | Homologous recombination | Mismatch repair |
| Main cancers in women | Breast (often triple-negative), high-grade serous ovarian and tubal | Breast (often hormone-receptor positive), ovarian, [pancreas](https://durgical.com/en/anatomy/pancreas/), melanoma | Colorectal and endometrial; also ovarian, stomach, urinary tract |
| Ovarian risk | Highest; cancers start earlier | Lower than BRCA1; later onset | Raised, varies with the gene |
| Risk-reducing gynaecological surgery | Tubes and ovaries removed, typically between 35 and 40 | Tubes and ovaries removed, typically between 40 and 45 | Hysterectomy with tubes and ovaries after childbearing, timed by gene |
| Treatment clue in the tumour | PARP inhibitors | PARP inhibitors | Immunotherapy (checkpoint inhibitors) |

## Keys to the differential

- High-grade serous 'ovarian' cancer usually starts in the fimbrial end of the tube, which is why risk-reducing surgery always removes the tubes as well as the ovaries.
- Screening for ovarian cancer with [CA-125](https://durgical.com/en/biochemistry/topics/ca-125/) and ultrasound has not been shown to reduce deaths; risk-reducing salpingo-oophorectomy is the measure that works.
- Surgery before natural [menopause](https://durgical.com/en/physiology/menopause/) → abrupt oestrogen loss → [hot flushes](https://durgical.com/en/obstetrics-gynaecology/menopause-symptoms-hormone-therapy-and-long-term-health/), bone loss and cardiovascular risk; carriers without breast cancer are usually offered hormone therapy until the age of natural menopause.
- Combined hormonal contraception lowers ovarian cancer risk and is an option for carriers who have not had breast cancer.
- Breast risk in carriers is managed with yearly MRI and mammography from a younger age than average, or risk-reducing mastectomy; Lynch carriers have frequent colonoscopy.

## Next step / Initial management

- Refer to genetics or genetic counselling any woman with a red flag above; document the family tree.
- After a diagnosis of ovarian cancer: germline (and tumour) BRCA testing for every woman, which also guides PARP inhibitor treatment.
- Carrier: refer to a high-risk clinic for breast screening, timing of risk-reducing surgery and, in Lynch, colonoscopy.
- Offer cascade testing to first-degree relatives, men included: sons can carry and pass on the variant.
- Before surgery: discuss menopause, fertility and future pregnancy plans; offer [fertility preservation](https://durgical.com/en/obstetrics-gynaecology/fertility-preservation/) if she has not completed her family.

## Common traps

- **No family history means no BRCA test in ovarian cancer**: many carriers have no known affected relatives, so every woman with epithelial ovarian cancer is offered testing.
- **Yearly CA-125 and ultrasound protect a BRCA carrier**: screening has not reduced deaths, and removing the tubes and ovaries is what lowers the risk.
- **A negative test clears the family**: it is only reassuring when the family's own variant is known and absent; otherwise the family history still guides care.
- **A variant of uncertain significance is a positive result**: most are later classed as benign, so no surgery is based on one.
- **Removing the ovaries is enough**: the cancer usually starts in the tube, so the tubes must come out too.

## Test yourself

Think of the answer, then tap the question to see it.

## A 58-year-old with high-grade serous ovarian cancer has no relatives with cancer. Should she have BRCA testing?

Yes. Every woman with epithelial ovarian cancer is offered testing: many carriers have no family history, and the result guides PARP inhibitor treatment and her relatives' care.

## Why does risk-reducing surgery in a BRCA carrier remove the tubes and not only the ovaries?

Most high-grade serous cancers called ovarian start in the fimbrial end of the [uterine tube](https://durgical.com/en/histology/uterine-tube/).

## An endometrial tumour from a 44-year-old shows loss of MSH2 and MSH6 proteins. What does this suggest and what follows?

Possible Lynch syndrome: offer genetic counselling and germline testing; if confirmed, she needs colonoscopy surveillance and her relatives can be tested.

## A woman's sister carries a BRCA1 variant. She tests negative for that variant. What is her ovarian risk?

About the population risk: a negative result for a known family variant is a true negative.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/obstetrics-gynaecology/brca-and-lynch-syndrome-who-to-test-and-risk-reducing-options/)

## Elsewhere in DurgiPedia

- [Hereditary cancer syndromes: the table to know](https://durgical.com/en/general-pathology/hereditary-cancer-syndromes-the-table-to-know/)
- [Familial breast cancer: BRCA1, BRCA2 and others](https://durgical.com/en/general-pathology/familial-breast-cancer-brca1-brca2-and-others/)
- [Hereditary colorectal cancer: FAP and Lynch syndrome](https://durgical.com/en/general-pathology/hereditary-colorectal-cancer-fap-and-lynch-syndrome/)
- [High-grade serous carcinoma](https://durgical.com/en/general-pathology/high-grade-serous-carcinoma/)

## Connections

## See it in 3D 5

The structures of Durgical's 3D anatomy where it is found.

- [Uterine tubes](https://durgical.com/en/anatomy/uterine-tube/)
- [Infundibulum and fimbriae](https://durgical.com/en/anatomy/infundibulum-of-uterine-tube/)
- [Ovaries](https://durgical.com/en/anatomy/ovary/)
- [Body of uterus](https://durgical.com/en/anatomy/body-of-uterus/)
- [Mammary gland lobes](https://durgical.com/en/anatomy/mammary-gland/)

## Related 4

- [Ovarian cancer: spread, staging and treatment in outline](https://durgical.com/en/obstetrics-gynaecology/ovarian-cancer-spread-staging-and-treatment-in-outline/)
- [Endometrial cancer: staging and treatment in outline](https://durgical.com/en/obstetrics-gynaecology/endometrial-cancer-staging-and-treatment-in-outline/)
- [Breast cancer screening in Colombia](https://durgical.com/en/obstetrics-gynaecology/breast-cancer-screening-in-colombia/)
- [Fertility preservation](https://durgical.com/en/obstetrics-gynaecology/fertility-preservation/)

## Related conditions 6

- [Hereditary breast and ovarian cancer syndrome (BRCA1/BRCA2)](https://durgical.com/en/conditions/hereditary-breast-and-ovarian-cancer-syndrome/)
- [Lynch syndrome (hereditary non-polyposis colorectal cancer)](https://durgical.com/en/conditions/lynch-syndrome/)
- [Ovarian cancer](https://durgical.com/en/conditions/ovarian-cancer/)
- [Endometrial cancer](https://durgical.com/en/conditions/endometrial-cancer/)
- [Breast cancer](https://durgical.com/en/conditions/breast-cancer/)
- [Colorectal cancer](https://durgical.com/en/conditions/colorectal-cancer/)

## In Pharmacology 1

- [Ethinylestradiol + levonorgestrel](https://durgical.com/en/pharmacology/ethinylestradiol-levonorgestrel/)

[← All of obstetrics and gynaecology](https://durgical.com/en/obstetrics-gynaecology/)

Educational content; it does not replace assessment by a doctor or your institution's protocols, and it contains no doses. For heavy bleeding, a severe headache or blurred vision, a seizure, fever, strong abdominal pain or fewer baby movements, go to an emergency department at once.

Sources: [BRCA1 and BRCA2 Mutations](https://www.ncbi.nlm.nih.gov/books/NBK470239/) (StatPearls Publishing (NCBI Bookshelf), 2023); [Hereditary Nonpolyposis Colon Cancer (Lynch Syndrome)](https://www.ncbi.nlm.nih.gov/books/NBK564511/) (StatPearls Publishing (NCBI Bookshelf), 2025); [Lynch syndrome](https://medlineplus.gov/genetics/condition/lynch-syndrome/) (MedlinePlus Genetics (U.S. National Library of Medicine), 2024); [Ovarian cancer: MedlinePlus Genetics](https://medlineplus.gov/genetics/condition/ovarian-cancer/) (MedlinePlus, US National Library of Medicine, 2026).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/obstetrics-gynaecology/brca-and-lynch-syndrome-who-to-test-and-risk-reducing-options/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/obstetrics-gynaecology/brca-and-lynch-syndrome-who-to-test-and-risk-reducing-options/
